Natixis Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $269M | Buy |
|
|||||
2025
Q1 | $219M | Buy |
|
|||||
2024
Q4 | $181M | Buy |
|
|||||
2024
Q3 | $155M | Buy |
|
|||||
2024
Q2 | $135M | Buy |
|
|||||
2024
Q1 | $115M | Sell |
|
|||||
2023
Q4 | $99.3M | Sell |
|
|||||
2023
Q3 | $93.7M | Buy |
|
|||||
2023
Q2 | $47.2M | Sell |
|
|||||
2023
Q1 | $51.6M | Sell |
|
|||||
2022
Q4 | $47.8M | Buy |
|
|||||
2022
Q3 | $33M | Buy |
|
|||||
2022
Q2 | $21.8M | Sell |
|
|||||
2022
Q1 | $28.5M | Buy |
|
|||||
2021
Q4 | $25.3M | Buy |
|
|||||
2021
Q3 | $25.2M | Sell |
|
|||||
2021
Q2 | $25.8M | Buy |
|
|||||
2021
Q1 | $22.4M | Buy |
|
|||||
2020
Q4 | $19.2M | Buy |
|
|||||
2020
Q3 | $18.6M | Buy |
|
|||||
2020
Q2 | $16.2M | Buy |
|
|||||
2020
Q1 | $12.6M | Buy |
|
|||||
2019
Q4 | $8.96M | Buy |
|
|||||
2019
Q3 | $7.35M | Buy |
|
|||||
2019
Q2 | $6.1M | Buy |
|
|||||
2019
Q1 | $5M | Sell |
|
|||||
2018
Q4 | $4.84M | Buy |
|
|||||
2018
Q3 | $5.17M | Sell |
|
|||||
2018
Q2 | $4.68M | Sell |
|
|||||
2018
Q1 | $3.97M | Buy |
|
|||||
2017
Q4 | $2.92M | Buy |
|
|||||
2017
Q3 | $1.37M | Sell |
|
|||||
2017
Q2 | $1.38M | Buy |
|
|||||
2017
Q1 | $1.1M | Sell |
|
|||||
2016
Q4 | $1.04M | Sell |
|
|||||
2016
Q3 | $1.41M | Buy |
|
|||||
2016
Q2 | $1.34M | Buy |
|
|||||
2016
Q1 | $872K | Buy |
|
|||||
2015
Q4 | $799K | Sell |
|
|||||
2015
Q3 | $816K | Buy |
|
|||||
2015
Q2 | $685K | Buy |
|
|||||
2015
Q1 | $549K | Sell |
|
|||||
2014
Q4 | $444K | Buy |
|
|||||
2014
Q3 | $386K | Buy |
|
|||||
2014
Q2 | $343K | Buy |
|
|||||
2014
Q1 | $363K | Sell |
|
|||||
2013
Q4 | $418K | Buy |
|
|||||
2013
Q3 | $364K | Sell |
|
|||||
2013
Q2 | $299K | Buy |
|